Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

RT-PCR on Conjunctival Sample for the Detection of SARS-CoV-2 in Patients With Covid-19

  • Read more about RT-PCR on Conjunctival Sample for the Detection of SARS-CoV-2 in Patients With Covid-19

Neuraptive Therapeutics, Inc.

By efain on Wed, 05/20/2020 - 14:56
  • Read more about Neuraptive Therapeutics, Inc.
Expanded Access Listings

NTX-001 to Repair Peripheral Nerve Transection(s)

Conditions
Peripheral Nerve Transections, Acute or Planned in Upper Extremity and Facial Nerves

The proposed use of NTX-001 for transections of upper extremity and facial peripheralnerves, acutely or planned.

Cellphire Therapeutics, Inc.

By efain on Tue, 05/19/2020 - 15:25
  • Read more about Cellphire Therapeutics, Inc.

Renibus Pharmaceuticals

By efain on Tue, 05/19/2020 - 11:24
  • Read more about Renibus Pharmaceuticals

Biomarkers for Identification of COVID-19 Infection

  • Read more about Biomarkers for Identification of COVID-19 Infection

Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients

  • Read more about Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients

A Study of a Candidate COVID-19 Vaccine (COV001)

  • Read more about A Study of a Candidate COVID-19 Vaccine (COV001)

Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19)

  • Read more about Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19)

Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry

  • Read more about Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry

ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection

  • Read more about ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 249
  • Page 250
  • Page 251
  • Page 252
  • Current page 253
  • Page 254
  • Page 255
  • Page 256
  • Page 257
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA